That sounds like one of those abstract cryptic crossword clues. Would even have Confucius scratching his head.
Printable View
Im sure you can figure it out if you think real hard--but i dont think you really want to.
Rather than trying to cross examine KD to prove he is right--It makes more sense to examine PEB to prove they are on the right track.(In light of their performance in the last year)This is reason for concern IMO, and it seems logical for any investor who is considering investing (or leaving his investment in)
There are some pretty hard cold facts that can be researched,(if you have the scientific knowledge)
Otherwise you are running the risk of basing your investment decisions on emotions,and that doesnt always end well.
I read your posts when PEB was @1.70...and 1.50...1.30...1.10..1.00..86..76...and .65--Im under no illusions that you will ever change your stance regardless of what new information comes up--thats ok,everyone has their own investment strategy(I guess) but when new info comes along I believe its worth considering.
I dont think turning investment decisions into a competition is a good strategy,but as Mac would say..each to his/her own.
Nothing to do with you..I just dont agree with your process of investing in this share.--I hope that is ok to say,but like i nsaid its nothing personal--(I think your CDY is a good investment ATM)
Interesting to note that you only include the part where it was going down. I dont feel as if Im competing with anyone and you can disagree all you like. If you call the explosion of alleged facts from an alleged PHD under a pseudonym as new information you obviously need a new salt cellar. Patience is required on PEB and CDY not depression and focussing on miniscule fluctuations in the share price. So you do whatever you think is fit and Ill do what I think is fit and lets leave it at that before we bore everyone to tears.
Nothing personal, of course
I (surprisingly) concur with this.
I've stated previously, was that the smart way to realise the PEB IP would be to license the assay to one of the larger diagnostic companies. This would have been good for UoO but (assuming PEB become an amazing success) wouldn't create additional shareholder value.
I think the commercialisation unit of UoO (for some reason, full of people who hardly have any startup company experience) have realised the error of their ways after getting their fingers burnt.
Case in point is the below, fantastic new innovation project, opportunity to make a big impact in the industry etc.....
http://www.nbr.co.nz/article/squid-g...llion-cw-87314
FYI these sorts of new products are 'sustaining innovation', compared to the likes of A2 (where I'm a bull) is 'disruptive innovation', anyone who has read "The innovators solution' will understand my reasoning here.
More brilliance from Otago.
But I really struggle to see the wider economic benefit in selling the patent for "several million" , when it has such huge potential?
edit - are there examples of where UoO has had fingers burnt? You are surely not suggesting PEB has cost them?